Drug Update

Drug Update

New option for those starting HIV therapy

New option for those starting HIV therapy

Rilpivirine, a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor of HIV-1, approved for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-naïve adult patients.

COPD therapy now available in pill form

COPD therapy now available in pill form

Daliresp is a selective phosphodiesterase 4 inhibitor that reduces risk for chronic obstructive pulmonary disease exacerbations in severely effected patients with COPD that have chronic bronchitis and a history of exacerbations.

Tradjenta to reduce hemoglobin A1c levels

Tradjenta to reduce hemoglobin A1c levels

Linagliptin increases the concentrations of active incretin hormones, stimulating the release of insulin in a glucose-dependent manner and decreasing the levels of glucagon in the circulation.

Once-a-day gel for low testosterone

Once-a-day gel for low testosterone

Fortesta is a topical gel formulation of the androgen testosterone, indicated as replacement therapy in men for conditions associated with a deficiency or absence of the endogenous hormone.

Next post in Drug Update